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benefit over general anesthesia in on-pump 
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Abstract 
Background: Thoracic epidural anesthesia (TEA) has been proposed to improve and facilitate early postoperative 
outcome in cardiac surgery. The aim of our study was to analyze early postoperative outcome data of patients under-
going cardiac surgery under general anesthesia (GA) with comparison to patients receiving combined TEA and GA.
Methods: Medical records data from 288 patients who underwent elective on-pump cardiac surgery were retrieved 
and analyzed. Patients were divided into two study groups according to the type of anesthesia used: GA group 
(n = 141) and TEA group (n = 147). Early postoperative outcome data including quality of analgesia and major organ 
outcome parameters were compared between the study groups.
Results: There was no major difference in early postoperative outcome data between the study groups, except 
for shorter time to extubation (6.0 ± 10.0 vs. 6.9 ± 8.8 h, respectively, P < 0.05) and hospital stay (10.7 ± 5.9 vs. 
12.9 ± 8.8 days, respectively, P < 0.05) in TEA group compared to GA group. Also TEA group as compared to GA group 
had lower pain numeric rating scale scores (1 ± 1.1 vs. 1.4 ± 1.5 at 24 h, respectively, P < 0.05) and morphine require-
ments during the first 24 h after surgery (148.2 vs. 193 ± 85.4 μg/kg, respectively, P < 0.05).
Conclusion: Both anesthetic methods were equivalent in most postoperative outcome measures. Thoracic epidural 
analgesia provided superior pain relief, shorter time to extubation and earlier hospital discharge.
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Background
Epidural anesthesia is effectively applied in different types 
of surgery to improve perioperative outcome (Block et al. 
2003). In cardiac surgery, high thoracic epidural anesthe-
sia (TEA) offers several advantages including thoracic 
sympathicolysis, attenuated stress response and myocar-
dial blood flow redistribution (Chaney 2006). In previous 
studies, these effects were coupled with improved anal-
gesia (Liu et al. 2004), earlier extubation time (Liu et al. 
2004), less respiratory complications (Liu et  al. 2004; 
Ballantyne et  al. 1998), decreased incidence of arrhyth-
mias (Svircevic et al. 2011) and postoperative myocardial 
infarction (Beattie et al. 2001). However, as recent meta-
analyses show, no mortality benefit has been proven so 
far (Svircevic et al. 2013).
Despite these advantages, the application of TEA in clin-
ical practice is more or less limited because of its poten-
tial risk of adverse events such as epidural hematoma or 
abscess resulting in spinal cord compression (Hemmerling 
et al. 2013). Furthermore, TEA may also be a risk factor for 
arterial hypotension and hemodynamic instability in the 
postoperative period (Gramigni et al. 2013).
In this retrospective study, we aimed to compare the 
effects of conventional general anesthesia (GA) and 
combined TEA and GA on early postoperative outcome 
measures including the quality of analgesia, hemody-
namic stability and perioperative mortality in patients 
undergoing elective cardiac surgery with cardio-pulmo-
nary bypass.
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Methods
This study was approved by local ethics committee of 
General University Hospital in Prague.
Patient population
All adult patients undergoing any elective cardiac surgi-
cal procedure with the use of cardio-pulmonary bypass 
from January 2012 through September 2012.
Data retrieval
Data from hospital records and local registry were col-
lected and reviewed retrospectively. Patient demo-
graphics, preoperative status, operative risk assessment 
calculated by EuroSCORE II scoring system (ES II), 
operative and early postoperative outcome data were 
retrieved and analyzed. The latter included major organ 
system outcome parameters, length of hospital stay, 
perioperative mortality and quality of analgesia, which 
was evaluated using Numeric rating scale (NRS) scoring 
at rest recorded every 6 h for 3 days postoperatively. The 
procedure was considered to be elective if the patient was 
admitted to hospital 1 day prior to surgery excluding all 
the acute conditions as defined by ES II criteria.
Study protocol
All patients included in the study were divided into two 
groups according to the type of anesthesia used. The first 
group (GA group) comprised of patients undergoing 
cardiac surgery in sole general anesthesia (GA), receiv-
ing conventional, protocol-based opioid analgesia post-
operatively. The second group (TEA group) consisted of 
patients undergoing surgery under combined TEA and 
GA and receiving postoperative epidural analgesia. All 
retrieved patient’s data were then analyzed and compared 
between the two study groups.
Premedication and anesthetic technique
There is a standard premedication and anesthetic pro-
tocol for cardiac surgical patients in our institution. All 
patients receive 0.25–0.5  mg of alprazolam orally 1  h 
prior to arrival to the operating room. General anes-
thesia is induced with an intravenous bolus of propofol 
(1.5–2  mg/kg), sufentanil (0.5  μg/kg) and rocuronium 
(0.4–0.6  mg/kg). GA is maintained using isoflurane of 
minimal alveolar concentration 0.7–1.0 in a gas mix-
ture of oxygen and air. Additional boluses of 25–50  μg 
of sufentanil are administered in case of analgesic insuf-
ficiency. No other myorelaxation is used throughout the 
procedure.
The epidural puncture was performed in the TEA 
group at the level Th1/2–Th2/3 using an 18-gauge Tuohy 
epidural needle (Perican, B. Braun, Melsungen, Germany) 
under local anesthesia in sitting or lateral decubitus 
position before induction of anesthesia. Coagulation pro-
files of all patients were normal before epidural puncture. 
The epidural space was identified using hanging drop or 
loss of resistance technique and 10 mL of 0.25 % bupiv-
acaine was administered as a bolus into the space. After-
wards, an epidural catheter (Perifix-Katheter, B. Braun, 
Melsungen, Germany) was inserted 2–4  cm into the 
epidural space. The level of anesthesia was determined 
by loss of pinprick sensation (Th1–Th10). Then, continu-
ous epidural infusion using plain 0.25 % bupivacaine was 
applied with a rate of 7–10 mL/h till the end of surgery. 
After epidural puncture GA was induced and maintained 
using isoflurane in the same dosage as in the GA group. 
When required additional sufentanil was administered 
according to the pain response.
Postoperative management
After the transfer to ICU, all patients were weaned off the 
ventilator and extubated according to local extubation 
protocol. This included fully awake, cooperative patients 
with stable hemodynamic parameters, without signifi-
cant blood loss (<200 mL/2 h) and with acceptable arte-
rial blood gases parameters (i.e. PaO2  >  60  mmHg and 
PaCO2 < 60 mmHg) on non-aggressive ventilation (pres-
sure support ventilation, PEEP ≤ 5 cm H20, FiO2 ≤ 0.4, 
pressure support ≤6  cm H20 and respiration frequency 
≥10/min). On the first postoperative day, pain manage-
ment in the GA group was conducted by intravenous 
administration of 1 g of paracetamol every 6 h combined 
with a nurse-driven intravenous morphine protocol. 
Patients with NRS scores <5 received 1 mg of intravenous 
morphine and 2  mg of morphine were administered to 
patients with NRS scores >5. The minimal time interval 
between 2 morphine injections was 10 min and the maxi-
mal dose was 20 mg per 12 h. In case of inadequate anal-
gesia further on, additional morphine was administered 
on doctor’s request.
After 24 h analgesic therapy continued with 1 g of oral 
paracetamol six hourly and 20  mg of oral oxycodone 
twelve hourly. Postoperative analgesia in the TEA group 
was provided by continuous infusion of local anesthet-
ics to epidural catheter (0.1  % bupivacaine by rate of 
3–8 mL/h) supplemented by the same paracetamol regi-
men as in the GA group. In case of epidural analgesia 
insufficiency, opioids were administered by the identical 
protocol as in the GA group.
Antiplatelet/anticoagulation therapy was started 6 h after 
the surgery if blood loss was less than 20  mL/h. Epidural 
catheter was removed on the fourth postoperative day with 
respect to safe withdrawal intervals of anticoagulants, i.e. 
4  h after stopping continuous infusion of unfractionated 
heparin, 12  h after last prophylactic dose of low-molecu-
lar weight heparin and 24 h after last therapeutic dose of 
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low-molecular weight heparin. Chest tubes were removed 
on the second or third postoperative day.
Criteria for intensive care unit discharge were as fol-
lows: fully alert and cooperative patient without significant 
neurological impairment, hemodynamic stability without 
inotropic or vasopressor therapy, no hemodynamically sig-
nificant arrhythmias, spontaneous breathing with arterial 
oxygen saturation >90 % at FiO2 ≤  50 % via a facemask, 
urine output >0.5 mL/kg/h, chest tube drainage <20 mL/h. 
Criteria for hospital discharge were as follows: hemody-
namically stable with controlled arrhythmias, independent 
in ambulation and feeding, afebrile with no infections and 
clean wound, normal voiding and bowel movements, full 
oral diet, pain controlled by oral medication.
Statistical analysis
Data are presented as mean ±  standard deviation. SPSS 
13.0 software (SPSS Inc., Chicago, IL, USA) was used for 
statistical analysis. A Chi square test was used for com-
parisons of preoperative and postoperative qualitative 
parameters, followed by Fisher’s exact test. Normal distri-
bution was tested for all quantitative parameters. Mann–
Whitney non-parametric test was used for comparisons 
of quantitative parameters between the study groups. P 
values <0.05 were considered statistically significant.
Results
There were 288 patients included in the study, 141 in the 
GA group and 147 in the TEA group.
Demographic, preoperative and peroperative data
 There was no difference in demographic and preop-
erative data between the study groups, except for higher 
proportion of older patients and higher incidence of left 
ventricular systolic dysfunction in the GA group as com-
pared to the TEA group (Table 1). Also no difference was 
found in the type of antihypertensive medication admin-
istered prior to surgery in the TEA group compared to 
the GA group: B-blockers (66.7 and 67.4 % respectively, 
P  =  0.99), angiotensin-converting enzyme inhibitors 
(44.2 and 49.6  %, P  =  0.65), sartans (15.6 and 12.1  % 
respectively, P  =  0.68) and calcium-channel blockers 
(23.8 and 19.9 % respectively, P = 0.72).
Operative data analysis revealed higher incidence of 
aortic valve replacement, aortic surgery and reopera-
tions in the TEA group (Table 2). On the contrary, more 
coronary artery bypass grafting procedures were per-
formed in the GA group (Table  2). No other significant 
differences in operative data including aortic cross-clamp 
time and length of cardio-pulmonary bypass were noted. 
Operative risk severity, as assessed by EUROScore II, was 
similar in the two study groups, without a significant dif-
ference (Table 2).
Table 1 Demographics and preoperative data
EUROSCORE II European System for Cardiac Operative Risk Evaluation II, BSA 
body surface area, BMI body mass index, CAD coronary artery disease, LV EF 
left ventricular ejection fraction, RV right ventricular, COPD chronic obstructive 
pulmonary disease (FEV1 ˂80 %, FEV1/FVC˂70 %), TIA transitory ischemic attack, 
NYHA New York Heart Association heart failure classification
Italic values indicate significance value of P < 0.05
GA, n = 141 TEA, n = 147 P value
EUROSCORE II 3.5 ± 3.8 3.65 ± 3.64 0.694
Age (years) 66.9 ± 10.9 64.3 ± 9.8 0.041
Height (meters) 1.70 ± 0.09 1.71 ± 0.09 0.137
Weight (kilograms) 80.5 ± 16.3 82.9 ± 17 0.104
BSA (m2) 1.91 ± 0.20 1.96 ± 0.21 0.064
BMI (kg/m2) 27.8 ± 4.5 28.4 ± 5.5 0.395
Male (female) 94 (47) 99 (48) 0.902
CAD 82 (58.2 %) 76 (51.7 %) 0.066
Arterial hypertension 114 (80.9 %) 109 (74.1 %) 0.208
LV EF (%) 54.4 ± 12.6 56.8 ± 11.2 0.044
RV dysfunction 14 (9.9 %) 15 (10.2 %) 0.996
COPD 32 (22.7 %) 40 (27.2 %) 0.295
Diabetes mellitus 27 (19.1 %) 38 (25.9 %) 0.832
Stroke/TIA 15 (10.6 %) 16 (10.9 %) 0.946
NYHA 0.370
 I 10 (7.1 %) 14 (9.5 %)
 II 76 (53.9 %) 83 (56.5 %)
 III 52 (36.9 %) 46 (31.3 %)
 IV 3 (2.1 %) 4 (2.7 %)
Serum creatinine (µmol/L) 91.6 ± 27.4 94.4 ± 35.7 0.999
Table 2 Operative data
CABG coronary artery bypass grafting, AVR aortic valve replacement, MVR mitral 
valve replacement, MV mitral valve, TV tricuspid valve, CPB cardio-pulmonary 
bypass
Italic values indicate significance value of P < 0.05
GA, n = 141 TEA, n = 147 P value
Type of surgery
 CABG 44 (31.2 %) 23 (15.6 %) 0.002
 AVR 22 (15.6 %) 37 (25.2 %) 0.044
 MVR 8 (5.7 %) 4 (2.7 %) 0.210
 MV repair 4 (2.8 %) 9 (6.1 %) 0.783
 Aortic surgery 4 (2.8 %) 13 (8.8 %) 0.031
 Combined procedure 50 (35.5 %) 54 (36.7 %) 0.561
 Other 9 (6.4 %) 7 (4.9 %) 0.210
Reoperation 3 (2.1 %) 12 (8.2 %) 0.021
Re-exploration for
 Bleeding 3 (2.1 %) 2 (1.4 %) 0.618
 Tamponade 0 2 (1.4 %) 0.586
Blood loss (mL) 915 ± 340 964 ± 457 0.311
Aortic cross clamp time (min) 75 ± 33 78 ± 41 0.847
CPB time (min) 111 ± 41 118 ± 62 0.961
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The total dose of sufentanil administered during sur-
gery was significantly lower in the TEA group compared 
to the GA group (0.65  ±  2.21 and 2.67  ±  0.83  µg/kg 
respectively, P < 0.05).
Quality of analgesia
NRS scores were significantly lower at 6, 12, 18, 24 h after 
surgery in the TEA group compared to the GA group. 
Subsequently, in the following 48 h, NRS scores did not 
differ between the study groups (Fig.  1). The total mor-
phine requirements were lower in the TEA group com-
pared to the GA group (148.2 ± 82.5 and 193 ± 85.4 µg/
kg respectively, P < 0.05).
Postoperative outcome data
There was no difference in all major organ outcome 
parameters between the study groups (Tables 3, 4). Total 
dose of norepinephrine and duration of vasopressor sup-
port tended to be lower in the TEA group compared to 
the GA group, but did not reach a statistical significance 
(Table  3). Time to extubation was significantly lower in 
the TEA group compared to the GA group (Table 3).
Length of hospital stay and early mortality
There was a shorter hospital stay in the TEA group 
compared to the GA group, however no difference was 
found in the ICU length of stay between the study groups 
(Table 5). Also no significant difference in ICU or hospi-
tal mortality was noted (Table 5).
No serious complications of epidural catheter inser-
tion, including clinically significant epidural hematoma 
or abscess were identified.
Discussion
Our retrospective analysis showed that the use of high 
TEA was associated with shorter time to extubation, 
reduced length of hospital stay and superior analgesia 
in comparison to GA in patients undergoing elective 
on-pump cardiac surgery. Other major organ outcome 
parameters including early mortality did not differ 
between the study groups.
Since its first use in cardiac surgery in Clowes et  al. 
(1954), TEA has been used primarily to provide reliable 
postoperative analgesia. Pain management in postopera-
tive period is one of the most essential components of 
Fig. 1 Mean postoperative pain scores at rest by group (TEA, black; GA, white) and time (hours after surgery). Data are presented as mean ± stand-
ard deviation. TEA thoracic epidural anesthesia, GA general anesthesia, NRS numeric rating scale. *P < 0.05
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postsurgical patients care and insufficient analgesia may 
lead to many unfavorable outcome, including hemody-
namic instability, impaired immune response, extensive 
catabolism, and hemostatic disorders (Weissman 1990). 
Epidural anesthesia in cardiac surgery provides superior 
pain relief in comparison to standard intravenous opioid 
treatment (Liu et al. 2004) and our study results confirm 
these findings. However, we found that analgesic efficacy 
of TEA was better only in the immediate postoperative 
period during the first 24  h (Fig.  1). Afterwards pain 
scores did not differ between the study groups which is 
also in agreement with previous reports (Clowes et  al. 
1954). Concomitantly, patient’s morphine requirements 
were significantly lower in the TEA group. Deleterious 
effects of opioid analgesia include respiratory depres-
sion, sedation, vomiting and nausea, constipation, uri-
nary retention, pruritus and ileus and may finally worsen 
patient’s postoperative outcome (Mehta and Arora 2014). 
Therefore, from this point of view, the use of TEA seems 
to be also advantageous.
In accordance with earlier studies (Liu et  al. 2004), 
we found that the time to extubation was significantly 
shorter in patients with TEA (Table 3). Early extubation 
in conjunction with effective analgesia and rapid mobili-
zation constitutes a cornerstone of fast-tracking concept 
in anesthesia (Nanavati and Prabhakar 2014) and forms 
a necessary basis especially for prevention of postopera-
tive respiratory complications. Postoperative pulmonary 
dysfunction (PPD) is common and significant after car-
diac surgery, as it contributes to increased morbidity, 
mortality and prolongs hospitalization stay (Wynne and 
Botti 2004). Its clinical manifestations include pleural 
effusion, atelectasis, postoperative hypoxemia and acute 
respiratory distress syndrome. Pathophysiology of PPD 
is complex and its mechanisms are not fully understood. 
However, the most significant factors include surgery 
related factors, effect of general anesthesia with mechani-
cal ventilation, cardiopulmonary bypass and systemic 
inflammatory response syndrome (Badenes et  al. 2015). 
Additionally, postoperative pain and impairment of dia-
phragmatic function are also important determinants of 
such pulmonary dysfunction (Diehl et  al. 1994). Never-
theless, in our study, better analgesia and shorter venti-
lation times in the TEA group did not result in reduced 
incidence of these respiratory complications, as they were 
equally frequent in both study groups (Table 3). That is in 
contrast to the latest meta-analysis that showed a lower 
risk of respiratory events for patients receiving TEA dur-
ing surgery compared with those receiving GA alone 
(Svircevic et al. 2013). However, in a recent study, it was 
demonstrated that an early extubation (within 9  h after 
cardiac surgery) is associated with an improved outcome 
and was shown to be the best predictor of uncomplicated 
recovery (Camp et al. 2009). Even though our data show 
that time to extubation was shorter in the TEA group, 
this reduction was only of a mild degree (6.0  h in TEA 
Table 3 Cardiovascular and respiratory complications
IABP intra-aortic balloon pump, NE norepinephrine, TIA transitory ischemic 
attack, ICU intensive care unit
Italic value indicates significance value of P < 0.05
GA, n = 141 TEA, n = 147 P value
Myocardial infarction 1 (0.7 %) 0 0.490
Low cardiac output 5 (3.5 %) 9 (6.1 %) 0.309
Ionotropes 28 (19.9 %) 33 (22.4 %) 0.591
IABP 3 (2.1 %) 7 (4.8 %) 0.336
Atrial fibrillation 37 (26.2 %) 44 (29.9 %) 0.486
NE support 92 (65.2 %) 100 (68 %) 0.882
NE > 0.1 µg/kg/min 29 (20.6 %) 31 (21.1 %) 0.806
NE total dose (µg/kg) 211 ± 807 123 ± 289 0.260
NE support duration (h) 28 ± 36 21 ± 29 0.114
ICU fluid balance (mL) 3890 ± 1936 3518 ± 2405 0.124
Lung atelectasis 6 (4.3 %) 8 (5.4 %) 0.640
Pneumonia 1 (0.7 %) 4 (2.7 %) 0.371
Time to extubation (h) 6.9 ± 8.8 6.0 ± 10.0 0.002
Reintubation 4 (2.8 %) 2 (1.4 %) 0.428
Table 4 Renal, gastrointestinal, neurological and  infec-
tious complications
CRRT continuous renal replacement therapy, TIA transitory ischemic attack, ICU 
intensive care unit
GA, n = 141 TEA, n = 147 P value
Acute renal failure 5 (3.5 %) 4 (2.7 %) 0.746
CRRT 2 (1.4 %) 2 (1.4 %) 1.000
Peak serum creatinine (µmol/L) 99.6 ± 37.1 102.4 ± 40.3 0.864
Upper gastrointestinal bleeding 1 (0.7 %) 1 (0.7 %) 1.000
Mesenterial ischemia 1 (0.7 %) 1 (0.7 %) 1.000
Stroke/TIA 3 (2.1 %) 2 (1.4 %) 0.679
ICU delirium 8 (5.7 %) 7 (4.8 %) 0.728
Blood stream infection 0 2 (1.4 %) 0.498
Urinary tract infection 0 0
Surgical site infection 3 (2.1 %) 0 0.116
Table 5 Mortality and length of ICU/hospital stay
ICU intensive care unit
Italic value indicates significance value of P < 0.05
GA, n = 141 TEA, n = 147 P value
ICU mortality 3 (2.1 %) 4 (2.7 %) 1.000
Hospital mortality 5 (3.5 %) 5 (3.4 %) 0.998
Length of ICU stay (days) 5.5 ± 4 5.3 ± 3.1 0.814
Length of hospital stay (days) 12.9 ± 8.8 10.7 ± 5.9 0.019
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group vs. 6.9  h in GA group). Thus, both study groups 
generally fulfilled early extubation criteria, as identified 
by the above mentioned study, possibly having a favora-
ble impact on postoperative outcome in both groups. 
Similarly, pain relief was significantly better in the TEA 
group during the first postoperative day, however pain 
scores in both groups were generally low (average NRS at 
24 h of 1.4 ± 1.5 in GA group vs. 1 ± 1.1 in TEA group, 
P < 0.05), representing also a mild degree of postopera-
tive pain. These results show that morphine analgesia 
in the GA group provided sufficient pain relief and also 
enabled early extubation, resulting in similar incidence of 
PPD as in the TEA group.
Furthermore, the rest of major postoperative outcome 
parameters including neurologic complications, renal 
impairment, myocardial dysfunction, infective complica-
tions and perioperative mortality did not differ between 
the study groups either, which corresponds to the results 
of a recent, large meta-analysis (Svircevic et al. 2013). On 
the other hand, we also did not notice any reduction in 
the incidence of supraventricular arrhythmias which has 
been reported by our previous study with TEA awake 
patients (Porizka et al. 2011) and a meta-analysis (Svirce-
vic et  al. 2013). However, when looking at these pub-
lished data from meta-analysis more closely, we discover 
that in the large study by Scott et  al. (2001) B-blockers 
were discontinued 5  days preoperatively, which must 
have contributed significantly to increased incidence of 
postoperative arrhythmias. Subsequently, studies pub-
lished since then have been unable to repeat these results 
(Hansdottir et  al. 2006). All patients in our study were 
on the regular, anti-hypertensive medication including 
B-blockers until the day of surgery and their postopera-
tive administration was restored as soon as possible. This 
may be the reason, why the incidence was similar in both 
study groups, as many recent studies have shown that 
postoperative supraventricular tachyarrhythmias can be 
reduced just with the use of B-blockers, amiodarone or 
atrial pacing (Burgess et al. 2006).
Many factors other than type of anesthesia, including 
comorbidities, age, acuity and type of operative proce-
dure, influence final perioperative outcome. In our study, 
there were a few significant differences in preopera-
tive and operative data (Tables 1, 2) in the study groups. 
Nevertheless, most of these parameters are included in 
final operative risk severity score calculation, in our case 
widely used ES II which was validated in large popula-
tions of cardiac surgical patients (Biancari et  al. 2012). 
ESII was similar in both study groups (3.5 % in GA group 
and 3.65  % in TEA group), therefore we assume that 
these study groups were comparable. On the other hand, 
such ESII scores represent relatively low risk category 
of cardiac surgical patients. This may be the reason why 
we did not observe beneficial effects of epidural anes-
thesia (lower incidence of pulmonary complications and 
supraventricular arrhythmias) reported by recent meta-
analyses (Svircevic et  al. 2011, 2013) and these effects 
might become more apparent when higher risk patients, 
especially those with pulmonary or cardiac dysfunction, 
are involved.
As mentioned above, TEA represents one of the pos-
sible methods of fast-track anesthesia and there are stud-
ies reporting shorter length of hospital stay when using 
TEA (de Vries et  al. 2002). From that point of view, we 
present conflicting results. In our study, there was no dif-
ference in the duration of ICU stay, while hospital stay 
was shorter in the TEA group (Table 5). Considering that 
preoperative characteristics, most of operative data and 
early postoperative outcome did not differ between the 
study groups, it is most likely that this observation was 
not caused by TEA alone, as no epidural analgesia was 
used during the ward stay beyond the fourth postopera-
tive day. On the other hand, other factors that are not 
related to patient’s characteristics or anesthetic/surgical 
method used may play a role. These represent the local 
protocol of patient hospital discharge, which includes a 
factor of surgeon’s own decision process and preferences. 
Also a social aspect, reflecting whether the patient is dis-
charged from hospital to home/other medical facility and 
availability of spa care, is of significant importance and 
may finally affect the total length of hospital stay.
Despite all these potentially beneficial effects of TEA, 
its application in connection with cardiac surgery still 
remains very controversial. The widespread safety con-
cern of TEA is whether it promotes an extensive sympa-
thectomy with the resultant hypotension, hemodynamic 
instability and increased use of vasopressors. However, 
as both experimental (Taniguchi et al. 1997) and human 
(Magnusdottir et al. 1999) data show, sympathetic block 
does not extend below the sensory block, which typi-
cally extends from T1 to T8, and sympathetic tone is pre-
served in large splanchnic and limb vascular beds. In our 
study, hemodynamic stability and degree of hypotension 
were evaluated by the retrospective assessment of norepi-
ephrine (NE) use and the net fluid balance. No significant 
difference was found in the number of patients requiring 
NE support and the incidence of high level of NE support 
(>0.1  µg/kg/min) between the study groups (Table  3). 
There was a strong trend towards shorter duration and 
lower total dose of NE support in the TEA group, but it 
was not statistically significant (Table 3). We also evalu-
ated the total net fluid balance at the end of ICU stay, 
as fluid therapy constitutes the first line treatment in 
hypotensive states and therefore may reflect the degree 
of postoperative hemodynamic instability. Our results 
also show no major statistical difference in the net fluid 
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balance between the study groups (Table  3). Neverthe-
less, there are other major factors associated with hypo-
tension in the immediate postoperative period that may 
affect the final fluid balance and the use of vasopressors. 
These include the degree of blood loss, myocardial dys-
function with the need for inotropes, incidence of sep-
sis and length of cardio-pulmonary bypass (Fischer and 
Levin 2010). All these parameters did not differ between 
the study groups (Tables  2, 4) either. Additionally, anti-
hypertensive medication administered on the day of sur-
gery may also affect hemodynamic stability and need for 
vasopressors in perioperative period (Auron et al. 2011), 
however there were no differences in the type of anti-
hypertenzives given preoperatively in the study groups. 
Thus, all these findings indicate that the degree of hypo-
tension is not increased and hemodynamic stability is 
preserved in patients with TEA after cardiac surgery.
Another major concern associated with the use of TEA 
in cardiac surgery is the risk of epidural hematoma or 
abscess formation with possible catastrophic neurologi-
cal sequelae and there is clearly a big reluctance among 
anesthesiologists to place epidural catheters in these 
patients. Nevertheless, the latest epidural hematoma 
risk assessment in cardiac surgery stated a risk of 1:5493 
(Hemmerling et al. 2013) which is comparable to the risk 
in non-obstetrical surgery (Volk et al. 2012), and is gener-
ally considered to be relatively low. In the present study, 
we did not experience any of the above described serious 
complications in our TEA patients. On the other hand, 
all possible precautions must be undertaken to minimize 
this risk, including the acceptance of only normal coag-
ulation parameters and adequate withdrawal intervals 
of antithrombotic drugs before epidural puncture and 
insertion of epidural catheter (Gogarten et al. 2010). The 
time interval between epidural catheter placement and 
full heparinization in on-pump cardiac surgery should 
be minimally 1 h (Mehta and Arora 2014; Gogarten et al. 
2010).
Our study has a few limitations. The major one is its 
retrospective design and relatively small number of 
patients, especially for an analysis of mortality data. 
When evaluating the hemodynamic stability between the 
study groups, we used only indirect markers including 
use of NE and the net fluid balance, as the measurements 
of cardiac output and other derived hemodynamic meas-
urements including systemic vascular resistance were not 
routinely performed and calculated in every patient.
In conclusion, in this retrospective observational study, 
the effectiveness of TEA combined with general anes-
thesia followed by continuous epidural analgesia and 
the effectiveness of general anesthesia alone followed 
by the nurse-driven intravenous morphine analgesia 
were compared with respect to quality of analgesia and 
postoperative complications after cardiac surgery. Except 
for superior analgesia, TEA did not offer any major 
advantage concerning quality of recovery and morbidity 
compared to GA.
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